Chemotherapy for advanced non-small cell lung cancer
55 results
1 - 55
Chemotherapy for advanced non-small cell lung cancer - Chemotherapy for newly diagnosed advanced non-small-cell lung cancer
Chemotherapy for advanced non‐small cell lung cancer in the elderly population- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review
- Immune checkpoint inhibitors plus platinum‐based chemotherapy compared to platinum‐based chemotherapy with or without bevacizumab for first‐line treatment of older people with advanced non‐small cell lung cancer
- Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Therapeutic vaccines for advanced non‐small cell lung cancer
- Surgery for local and locally advanced non‐small cell lung cancer
- Anti‐TIGIT inhibitors plus PD‐1 or PD‐L1 inhibitors versus PD‐1 or PD‐L1 inhibitors for first‐line treatment of advanced non‐small cell lung cancer
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Concurrent chemoradiotherapy in non‐small cell lung cancer
- Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer
- First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
- Second‐line chemotherapy for non‐small cell lung cancer
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Cannabis‐based medicines and medical cannabis for adults with cancer pain
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
- Chemotherapy for advanced gastric cancer
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)